DNAprint Genomics (DNAG)

[worktoplay]

ice1051...If they turn us into a drug company with a late stage pipeline, that will seem small compensation.

Do you suppose Luchese was concerned about losing money and the management shares when he put $160K into the company?

IMO, we haven't seen the good stuff yet, but we do have a company with $400K in the bank and rapidly increasing revenues. Quite an improvement in my eyes.

I would also point out that as opposed to the first quarter results which were disappointing on the heels of a PR that stated $215K in revs versus $75K actual, this time Tony low balled the Wall Street Journal. In the article he said they try to keep $200K in the bank - actual $401K. He said $150K in revs - actual $255